Arijit Bhowmick

Title: Arijit Bhowmick: Innovator in RNA Aptamer Technology

Introduction

Arijit Bhowmick is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of RNA aptamer technology, holding a total of 3 patents. His work focuses on innovative methods and compositions that have the potential to impact medical treatments.

Latest Patents

Bhowmick's latest patents include "Stem-loop compositions and methods for inhibiting factor D." This application discloses methods and compositions for the inhibition of the alternative complement pathway. The methods involve the use of aptamers for inhibiting complement Factor D. Additionally, the application provides anti-Factor D aptamers for treating conditions such as dry age-related macular degeneration, geographic atrophy, wet age-related macular degeneration, or Stargardt disease. In some cases, stem-loop aptamers are provided for the inhibition of Factor D. Another significant patent is "Chemically modified RNA aptamers," which includes chemically modified ribonucleic acid (RNA) aptamers comprising various nucleotide modifications and methods of making these aptamers.

Career Highlights

Throughout his career, Bhowmick has worked with esteemed organizations such as the Albert Einstein College of Medicine and Vitrisa Therapeutics, Inc. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Bhowmick has collaborated with notable colleagues, including Matthew Levy and Carl Erickson. These partnerships have further enriched his research endeavors and innovation in the field.

Conclusion

Arijit Bhowmick is a prominent figure in the realm of RNA aptamer technology, with a focus on developing innovative solutions for medical challenges. His contributions through patents and collaborations highlight his commitment to advancing scientific knowledge and improving healthcare outcomes.